MedPath

Telormedix SA

Telormedix SA logo
πŸ‡¨πŸ‡­Switzerland
Ownership
Private
Established
2007-01-01
Employees
1
Market Cap
-
Website
http://www.telormedix.com

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
1 (100.0%)

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Phase 2
Completed
Conditions
Carcinoma in Situ
Non Muscle Invasive Bladder Cancer
Interventions
First Posted Date
2012-11-22
Last Posted Date
2015-02-10
Lead Sponsor
Telormedix SA
Target Recruit Count
12
Registration Number
NCT01731652
Locations
πŸ‡ΊπŸ‡Έ

BCG Oncology, Phoenix, Arizona, United States

πŸ‡ΊπŸ‡Έ

The Urology Center of Colorado, Denver, Colorado, United States

πŸ‡ΊπŸ‡Έ

Urologic Consultants of SE PA, Bala Cynwyd, Pennsylvania, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.